BackU.S. Stem Cell Overview

U.S. Stem Cell Other Assets

Latest other assets for USRM: $0.

Get informed when a big investor buys or sells

+ Follow
Other Assets
$0.00

Peer trimmed avg / median

Loading

U.S. Stem Cell Other Assets History

Loading

U.S. Stem Cell vs. peers: Other Assets Comparison

Loading

U.S. Stem Cell Other Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

U.S. Stem Cell (USRM) FAQ

The latest other assets for USRM is $0 as of December 2022. In the prior-year period, the figure was $0. Investors often review this figure alongside U.S. Stem Cell's historical trend and sector peers before judging valuation or financial health.

Over the past year, USRM's other assets moved from $0 to $0. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in U.S. Stem Cell's operating scale or balance-sheet position.

A other assets figure of $0 for USRM is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting USRM's other assets ($0), review year-over-year change from $0, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack U.S. Stem Cell's other assets against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.